Patents by Inventor Joon Bok Lee

Joon Bok Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190336684
    Abstract: Disclosed are a system, methods and computer-readable medium products that provide safety constraints for an insulin-delivery management program. Various examples provide safety constraints for a control algorithm-based drug delivery system that provides automatic delivery of a drug based on sensor input. Glucose measurement values may be received at regular time intervals from a sensor. A processor may predict future glucose values based on prior glucose measurement values. The safety constraints assist in safe operation of the drug delivery system during various operational scenarios. In some examples, predicted future glucose values may be used to implement safety constraints that mitigate under-delivery or over-delivery of the drug while not overly burdening the user of the drug delivery system and without sacrificing performance of the drug delivery system. Other safety constraints are also disclosed.
    Type: Application
    Filed: May 6, 2019
    Publication date: November 7, 2019
    Applicant: Insulet Corporation
    Inventors: Jason O'CONNOR, Joon Bok LEE, Trang LY, Yibin ZHENG, Thomas Arnold PEYSER, Jennifer Lena SCHNEIDER
  • Publication number: 20190336683
    Abstract: Disclosed are a system, methods and computer-readable medium products that provide safety constraints for an insulin-delivery management program. Various examples provide safety constraints for a control algorithm-based drug delivery system that provides automatic delivery of a drug based on sensor input. Glucose measurement values may be received at regular time intervals from a sensor. A processor may predict future glucose values based on prior glucose measurement values. The safety constraints assist in safe operation of the drug delivery system during various operational scenarios. In some examples, predicted future glucose values may be used to implement safety constraints that mitigate under-delivery or over-delivery of the drug while not overly burdening the user of the drug delivery system and without sacrificing performance of the drug delivery system. Other safety constraints are also disclosed.
    Type: Application
    Filed: May 3, 2019
    Publication date: November 7, 2019
    Applicant: Insulet Corporation
    Inventors: Jason O'CONNOR, Joon Bok LEE, Trang LY, Yibin ZHENG, Thomas Arnold PEYSER, Jennifer Lena SCHNEIDER
  • Patent number: 10413664
    Abstract: A model-based control scheme consisting of either a proportional-integral-derivative (IMC-PID) controller or a model predictive controller (MPC), with an insulin feedback (IFB) scheme personalized based on a priori subject characteristics and comprising a lower order control-relevant model to obtain PID or MPC controller for artificial pancreas (AP) applications.
    Type: Grant
    Filed: July 6, 2015
    Date of Patent: September 17, 2019
    Assignee: The Regents of the University of California
    Inventors: Francis J. Doyle, III, Eyal Dassau, Dale E. Seborg, Joon Bok Lee
  • Publication number: 20150306314
    Abstract: A model-based control scheme consisting of either a proportional-integral-derivative (IMC-PID) controller or a model predictive controller (MPC), with an insulin feedback (IFB) scheme personalized based on a priori subject characteristics and comprising a lower order control-relevant model to obtain PID or MPC controller for artificial pancreas (AP) applications.
    Type: Application
    Filed: July 6, 2015
    Publication date: October 29, 2015
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Francis J. Doyle, III, Eyal Dassau, Dale E. Seborg, Joon Bok Lee